BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 8646694)

  • 1. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined surgical and radiotherapeutic treatment of pelvic wall recurrences: report of experiences after 3 years].
    Höckel M; Knapstein PG; Hohenfellner R; Rösler HP; Kutzner J
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):169-76. PubMed ID: 8467983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel combined operative and radiotherapeutic treatment approach for recurrent gynecologic malignant lesions infiltrating the pelvic wall.
    Höckel M; Knapstein PG; Kutzner J
    Surg Gynecol Obstet; 1991 Oct; 173(4):297-302. PubMed ID: 1925900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
    Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241Am.
    Chung JY; Roberts K; Peschel RE; Nath R; Pourang R; Kacinski B; Wilson L
    Radiat Oncol Investig; 1997; 5(5):227-34. PubMed ID: 9372545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience.
    Brabham JG; Cardenes HR
    Am J Clin Oncol; 2009 Aug; 32(4):417-22. PubMed ID: 19451799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laterally extended endopelvic resection (LEER)--principles and practice.
    Höckel M
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S13-7. PubMed ID: 18723213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: first experience with 18 patients.
    Höckel M; Knapstein PG
    Gynecol Oncol; 1992 Jul; 46(1):20-8. PubMed ID: 1634136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.
    Martínez-Monge R; Jurado M; Cambeiro M; Valero J; Villafranca E; Alcázar JL
    Brachytherapy; 2006; 5(4):203-10. PubMed ID: 17118310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
    Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
    J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
    Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
    Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical hysterectomy as surgical salvage therapy for gynecologic malignancy.
    Terada K; Morley GW
    Obstet Gynecol; 1987 Dec; 70(6):913-5. PubMed ID: 3684129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.